IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and academic research

VANCOUVER, BC, May 20, 2024 /PRNewswire/ - Today, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP extract of Tabernanthe iboga available for use in ibogaine clinics

Related Keywords

Vancouver ,British Columbia ,Canada ,Gabon ,Nagoya ,Aichi ,Japan ,Canadian , ,Terragnosis Inc ,Ambio Life Sciences ,Life Sciences ,